xMAP Technology has been a tried and true platform for biological research and discovery for 27 years. From humble beginnings as a novel multiplexing technology, it has become the worldwide leader for bead-based multiplexed analysis and an indispensable tool in the toolbox of research and clinical laboratories across the globe. As of June 2022, over 60,000 peer-reviewed publications have been reported by investigators who use xMAP Technology in their work. This session will review some recent xMAP literature that highlight the versatility and flexibility of this innovative platform. We will discuss a variety of topics that all have one thing in common – xMAP Technology. Join us as we discuss some of the newest publications on biomarker research in cancer chemotherapy, autism, gut microbiome, and obesity, as well as studies on infectious diseases, including dengue fever, tuberculosis, HIV, and COVID-19.